Neovii Pharmaceuticals AG
Neovii is an independent, global biopharmaceutical company with a patient-focused mission to develop and bring to market novel life-transforming therapies to improve the outcomes in transplantation medicine, hemato-oncological and immune disorders. Neovii was founded following the acquisition of Fresenius Biotech inheriting more than three decades of experience in specialty pharmaceuticals. We welcome new business partnerships and product opportunities for development, distribution, in-licensing or acquisition that can help us achieve our mission of bringing life-transforming therapies to treat patients with unmet medical need around the world.
Find locations served, office locations
- Business Type:
- Industry Type:
- Market Focus:
- Globally (various continents)
- Passion : We are inspired by the meaningful work we do and are passionately committed to success.
- Openness : We are open-minded, implement creative solutions and encourage entrepreneurship.
- Ambition : We set clear, ambitious targets.
We are dedicated to bringing life-transforming therapies to patients with unmet needs around the world.
Neovii aspires to be a fully integrated global pharmaceutical company with several franchises focused on diseases with unmet needs. We continually support customers up and down the value chain and are always in pursuit of maximizing total patient care.
We believe that our competencies and strengths combined with our values and culture make Neovii an employer of choice.